Company: ELV
Filing Date: 2025-09-09
Form Type: 424B3
Source: 0001193125-25-199226
Chunk: 23

Company: Elevance Health, Inc.
Filing Date: 2025-09-09
Form: 424B3
Chunk 23
---
We May Issue Other Series of Debt Securities

The indenture permits us to issue different series of debt securities from time to time. The specific terms of each other series that we may
issue in the future may differ from those of the notes. The indenture does not limit the aggregate amount of debt securities that may be issued under the indenture, nor does it limit the number of other series or the aggregate amount of any
particular series. The 2028 notes will be limited initially to $750,000,000 aggregate principal amount, the 2032 notes will be limited initially to $750,000,000 aggregate principal amount, the 2036 notes will be limited initially to $1,000,000,000
aggregate principal amount and the 2055 notes will be limited initially to $500,000,000 aggregate principal amount. We may “re-open” any series of notes at any time without the consent of the
noteholders. We may issue additional securities from time to time after this offering. The notes of any series and any additional new notes at any time of such series subsequently issued under the indenture would be treated as a single series for
all purposes under the indenture, including, without limitation, waivers, amendments, redemptions and offers to purchase; provided that if such additional notes are not fungible with such notes for U.S. federal income tax purposes, the additional
notes will have a separate CUSIP number.

S-15

The indenture and the notes do not limit our ability to incur other debt or to issue other securities. When we refer to a series of debt securities, we mean a series, such as each of the series of notes we are offering by means of this prospectus supplement and the accompanying prospectus, issued under the indenture. When we refer to the notes or these notes, we mean each series of notes we are offering by means of this prospectus supplement and the accompanying prospectus. Defeasance The notes may be defeased, at our option, through legal defeasance or covenant defeasance as provided for in the indenture and as described in the accompanying prospectus under the captions “ Description of the Debt Securities—Defeasance” and “ Description of the Debt Securities—Satisfaction and Discharge.” Book-Entry Notes Each series of notes will be issued in the form of one or more global notes in definitive, fully registered form, without interest coupons (the “Global Note”). Each Global Note will be deposited with